ExoRisk
A standalone supplement to ExoAnalysis: one, three and five-year upside–downside risk for a public company, written for a portfolio-manager audience.
Analytics Outputs
What's in the Report
| What It Answers | What It Tells an Investor or Board |
|---|---|
| Where the Company Is Valued Today | A valuation assessment covering share price, analyst consensus rating, trailing and peer/industry P/E, PEG ratio and recent analyst targets — the baseline every horizon below is measured against. Where no traded multiple exists, that is stated rather than estimated. |
| What the Next Twelve Months Turn On | The one-year horizon: the specific catalysts and failure modes that would move the position within the year, each tied to an observable event rather than a sentiment. |
| Where the Medium-Term Risk Concentrates | The three-year horizon: the central case and the structural forces — adoption, funding, competitive substitution — most likely to compound in either direction over that span. |
| What the Long Horizon Depends On | The five-year horizon: the durable dependencies and regulatory shifts that decide whether today's position is defensible or eroded. |
| The Upside and Downside, Side by Side | A summary matrix pairing each upside catalyst against its corresponding downside risk, so the asymmetry of the position is legible at a glance rather than argued across pages. |
| What to Watch, Specifically | Named, checkable signals — a financing event, a named customer, an ownership or scale change — that would confirm or falsify the assessment, plus full sourcing and qualification of the evidence base. |
Key Use Cases
Portfolio monitoring
Investment committee
Diligence supplement
Risk horizon review
Report Pairing
Reads as a supplement to ExoAnalysis, which supplies the external diagnostic this risk horizon is built on. It is a standalone deliverable and does not require a survey.